Risks Exist, But Market Has Obvious Potential

BMI View: While Pakistan boasts a substantial population of 174mn people, annual per-capita expenditure on pharmaceuticals is very modest at just US$10. Despite expected economic progress, the majority of the population will continue to suffer from inadequate access to medicines and healthcare provision. Moreover, the country's attractiveness to foreign players will continue to be limited due to shortcomings in its political and regulatory

To read the full article, please choose one of the following options: